Back

Polymorphic size of Lipoprotein (a) and structural bioprosthetic valve degeneration

31 August 2024 (07:55 - 08:30)
Organised by: Logo
Congress Presentation Part of: Unravelling the pathophysiology of valvular heart disease Prosthetic Heart Valves ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Romain Capoulade

Institut du Thorax, Nantes (France)

4 More presentations in this session

Presentation thumbnail
new insights into the pathophysiology of rheumatic valve disease based on different genetic and proteomics profiles.
Doctor A. Almeida Valadares (Sao Paulo, BR)
Abstract Slides Video
Presentation thumbnail
Subendocardial ischemic-like state in patients with severe aortic stenosis: insights from myocardial histopathology and ultrastructure.
Doctor R. Reis Santos (Lisbon, PT)
Abstract Slides Video
Presentation thumbnail
Causal association of serum calcium, phosphate, vitamin D, parathyroid hormone, and FGF23 with the risk of aortic stenosis
Doctor W. Nie (Beijing, CN)
Abstract Slides Video
Presentation thumbnail
The effect of the LPA gene on aortic valve calcification in a Portuguese population
Doctor F. Sousa (Funchal, PT)
Abstract Slides Video

Access the full session

Session thumbnail
Unravelling the pathophysiology of valvular heart disease

The Event

Event poster

ESC Congress 2024

31 August 2024 07:55 CET
You may be interested in
thumbnail
Congress Presentation
The role of serum lipoprotein(a) levels in bioprosthetic aortic valve degeneration
thumbnail
Congress Presentation
Lp(a) and aortic stenosis: epidemiology
thumbnail
Congress Presentation
High Lp(a) levels are a potential risk factor for aortic valve interventions in patients with bicuspid aortic valve

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources